Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-006602
Filing Date
2021-03-23
Accepted
2021-03-23 09:20:41
Documents
73
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1422995
2 ex23-1.htm EX-23.1 3806
3 ex31-1.htm EX-31.1 12076
4 ex31-2.htm EX-31.2 12234
5 ex32-1.htm EX-32.1 7006
6 ex32-2.htm EX-32.2 6944
  Complete submission text file 0001493152-21-006602.txt   5286696

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE pulm-20201231.xml EX-101.INS 776321
8 XBRL SCHEMA FILE pulm-20201231.xsd EX-101.SCH 61125
9 XBRL CALCULATION FILE pulm-20201231_cal.xml EX-101.CAL 63506
10 XBRL DEFINITION FILE pulm-20201231_def.xml EX-101.DEF 203082
11 XBRL LABEL FILE pulm-20201231_lab.xml EX-101.LAB 430007
12 XBRL PRESENTATION FILE pulm-20201231_pre.xml EX-101.PRE 311697
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36199 | Film No.: 21763338
SIC: 2834 Pharmaceutical Preparations